8-K: Cardinal Health Secures $1 Billion Revolving Credit Facility

Cardinal Health, Inc. has entered into a new 364-day, $1.0 billion revolving credit agreement to support general corporate purposes and its commercial paper program.

Summary

• Cardinal Health, Inc. (the Company) entered into a 364-Day Credit Agreement on October 7, 2025, with Bank of America, N.A. as Administrative Agent and other lenders.
• The agreement provides access to $1.0 billion in revolving credit, effective through October 6, 2026.
• This new facility replaces a similar 364-Day Credit Agreement that expired in October 2024.
• Proceeds are designated for general corporate purposes and to back the Company's commercial paper program.
• A key financial covenant requires the Company to maintain a Consolidated Net Leverage Ratio of no greater than 3.75 to 1.00 as of the last day of any fiscal quarter.
• A temporary "Leverage Holiday" allows the Consolidated Net Leverage Ratio to increase to 4.25 to 1.00 for the first four fiscal quarters following a Material Acquisition of $500 million or more.
• The Company has an option to convert outstanding loans on the Termination Date into non-revolving term loans, repayable one year after the Termination Date (October 6, 2027).

Sentiment

Score: 6

Explanation: The filing describes a routine and expected renewal of a credit facility, which is a positive for maintaining liquidity and financial flexibility. There are no significant new risks or negative surprises. The 'expected' nature of the event prevents a higher score, but the successful renewal is a stable, slightly positive indicator.

Positives

• Secured $1.0 billion in revolving credit, ensuring continued liquidity and financial flexibility.
• The facility supports general corporate purposes and backs the Company's commercial paper program, maintaining access to short-term financing.
• Includes a "Term-Out Option" allowing conversion of outstanding loans into non-revolving term loans, providing flexibility for longer-term financing if needed.
• The renewal of the credit facility is a routine financial management action, indicating ongoing access to capital markets.

Negatives

• No explicit negative aspects are highlighted in the filing, as it describes a routine credit facility renewal.

Risks

• Failure to maintain the Consolidated Net Leverage Ratio covenant (no greater than 3.75 to 1.00, or 4.25 to 1.00 during a Leverage Holiday) could trigger a default.
• Customary events of default, including non-payment of principal or interest and breaches of covenants, could lead to acceleration of obligations.
• Reliance on the commercial paper program, which is backed by this facility, exposes the company to short-term market conditions.
• Changes in capital adequacy regulations or other laws could increase costs for lenders, which may be passed on to the Company.
• Litigation or contingent obligations exceeding $250,000,000 not covered by insurance could trigger a default.
• Environmental liabilities or non-compliance with Environmental Laws that could have a Material Adverse Effect.
• Potential for a "Change in Control" event, as defined, which would constitute a Default.

Future Outlook

The Company has the option to convert any outstanding loans on the Termination Date (October 6, 2026) into non-revolving term loans, which would then be repaid in full one year later, on October 6, 2027. This provides flexibility for managing its debt maturity profile.

Management Comments

• The Company entered into the Credit Agreement following the expiration of the 364-Day Credit Agreement into which it entered in October, 2024.
• This revolving credit facility may be used for general corporate purposes and backs the Company's commercial paper program.

Industry Context

The renewal of a 364-day revolving credit facility is a standard practice for large, publicly traded companies like Cardinal Health to ensure ongoing access to liquidity and to support short-term financing needs, such as commercial paper programs. This action reflects prudent financial management in the healthcare distribution and services industry, where maintaining robust working capital and flexible financing options is crucial for operations and potential strategic initiatives.

Comparison to Industry Standards

• The $1.0 billion revolving credit facility is a common size for a company of Cardinal Health's scale in the healthcare distribution sector, comparable to facilities maintained by peers like McKesson Corporation or AmerisourceBergen Corporation.
• The 364-day term is typical for such facilities, often structured to avoid being classified as long-term debt for certain accounting purposes, while providing flexibility for annual renewal or conversion.
• The Consolidated Net Leverage Ratio covenant of 3.75x (with a temporary 4.25x for acquisitions) is within the typical range for investment-grade rated companies in this industry, balancing financial flexibility with creditor protection.
• The inclusion of a "Term-Out Option" is a standard feature in many corporate credit agreements, offering an additional layer of liquidity management.

Corporate Governance

Related Party Transactions

• Certain financial institutions party to the Credit Agreement (or their affiliates) and dealers under the Company's commercial paper program have performed and may in the future perform various lending, commercial banking, investment banking, financial advisory, securitization, trustee, or other services for the Company.
• The Company pays these financial institutions customary fees and expenses for these services.

Stakeholder Impact

• Shareholders: Provides assurance of continued liquidity and financial stability, supporting ongoing operations and potential growth initiatives.
• Creditors: The credit facility enhances the Company's ability to meet its financial obligations, including backing its commercial paper program, which benefits short-term creditors. The financial covenants provide a measure of protection.
• Employees, Customers, Suppliers: Stable financing supports the Company's ability to maintain operations, pay employees, fulfill customer orders, and pay suppliers.

Next Steps

• Utilize the $1.0 billion revolving credit facility for general corporate purposes and to back the commercial paper program.
• Monitor compliance with the Consolidated Net Leverage Ratio covenant.
• Potentially exercise the Term-Out Option on October 6, 2026, to convert outstanding loans into non-revolving term loans.
• Repay any outstanding term loans by October 6, 2027, if the Term-Out Option is exercised.

Key Dates

Recommendation

This filing details a routine renewal of a revolving credit facility, a standard corporate finance activity. It ensures continued liquidity and supports the commercial paper program, which is a positive for operational stability. However, it does not introduce new strategic initiatives, significant financial performance updates, or unexpected risks that would warrant a change in investment recommendation. The terms and covenants are typical for a company of this size and industry, suggesting no material change to the investment thesis.

Keywords

Cardinal Health, Credit Agreement, Revolving Credit, Debt Facility, Corporate Finance, Liquidity, Commercial Paper, SEC Filing, 8-K, Financial Covenant, Leverage Ratio, Term-Out Option